Citius Oncology (CTOR) Notes Payables (2023 - 2026)

Citius Oncology (CTOR) has 4 years of Notes Payables data on file, last reported at $3.8 million in Q1 2026.

• On a quarterly basis, Notes Payables changed 0.0% year-over-year to $3.8 million in Q1 2026; TTM through Mar 2026 was $3.8 million, a 0.0% change from a year earlier, with the FY2025 full-year figure at $3.8 million, changed 0.0% from the prior year.
• Notes Payables for Q1 2026 stood at $3.8 million, roughly flat from $3.8 million in the prior quarter.
• Over the last five years, Notes Payables for CTOR reached as high as $3.8 million in Q3 2024 and fell as low as $1.3 million in Q4 2023.
• Historically, Notes Payables has averaged $3.1 million across 4 years, with a median of $3.8 million in 2024.
• Across the five-year window, Notes Payables surged 187.89% in 2024 and changed 0.0% in 2025, its largest moves.
• Year by year, Notes Payables stood at $1.3 million in 2023, then jumped by 187.89% to $3.8 million in 2024, then changed by 0.0% to $3.8 million in 2025, then changed by 0.0% to $3.8 million in 2026.
• Per Business Quant data, the three most recent Notes Payables figures were $3.8 million in Q1 2026, $3.8 million in Q4 2025, and $3.8 million in Q3 2025.